A team led by Dr. Eddie Imada, assistant professor of research in pathology and laboratory medicine, has been awarded a three-year, $1.5 million United States Department of Defense grant for research on a cellular process called alternative polyadenylation and its role in prostate cancer.
Could heparin offer new hope in the fight against dementia?
Heparin therapy delays Alzheimer’s diagnosis by one to two years, offering potential insights into new protective treatments. Large-scale health records show a promising association between
October 10, 2024